![A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7249998/bin/medi-99-e20048-g001.jpg)
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC
![Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine](https://i1.rgstatic.net/ii/profile.image/272263815626776-1441924160343_Q512/Ioannis-Grivas.jpg)
Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine
![Οστεονέκρωση μηριαίας κεφαλής μετά από εξάρθρημα ισχίου με κάταγμα κοτύλης | 77ο Πανελλήνιο Συνέδριο ΕΕΧΟΤ Οστεονέκρωση μηριαίας κεφαλής μετά από εξάρθρημα ισχίου με κάταγμα κοτύλης | 77ο Πανελλήνιο Συνέδριο ΕΕΧΟΤ](https://eposters.betterevents.io/eexot2021/web/sites/default/files/pdfpreview/418-OSTEONEKROSI%20MIRIAIAS%20KEFALIS%20META%20APO%20EXARThRIMA%20ISHIOY%20ME%20KATAGMA%20KOTYLIS.png)
Οστεονέκρωση μηριαίας κεφαλής μετά από εξάρθρημα ισχίου με κάταγμα κοτύλης | 77ο Πανελλήνιο Συνέδριο ΕΕΧΟΤ
![Ο Άγιος Ιωάννης ο Πρόδρομος. Εικόνα στον Άγιο Νικόλαο. (1815). Έργο του Σπύρου Βεντούρα. | Painting, Art Ο Άγιος Ιωάννης ο Πρόδρομος. Εικόνα στον Άγιο Νικόλαο. (1815). Έργο του Σπύρου Βεντούρα. | Painting, Art](https://i.pinimg.com/736x/f4/fd/10/f4fd10640022a4855e65d7eb853a3267.jpg)
Ο Άγιος Ιωάννης ο Πρόδρομος. Εικόνα στον Άγιο Νικόλαο. (1815). Έργο του Σπύρου Βεντούρα. | Painting, Art
![Ioannis XENAKIS | Assistant Professor | PhD | University of the Aegean, Mytilene | Department of Product and Systems Design Engineering Ioannis XENAKIS | Assistant Professor | PhD | University of the Aegean, Mytilene | Department of Product and Systems Design Engineering](https://i1.rgstatic.net/ii/profile.image/953754731958276-1604404256681_Q512/Ioannis-Xenakis.jpg)
Ioannis XENAKIS | Assistant Professor | PhD | University of the Aegean, Mytilene | Department of Product and Systems Design Engineering
![Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel](https://i.pinimg.com/originals/b9/fd/a9/b9fda93ec37328ca7090c095e52592dd.jpg)
Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel
![Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering](https://i1.rgstatic.net/ii/profile.image/272261684920337-1441923652186_Q512/Kostas-Spyrou-3.jpg)
Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering
![PDF) Birds, stars and a homometric occurrence: the case of Alcm. frg. 3 Cal., vv. 87~101 | Alessio Faedda - Academia.edu PDF) Birds, stars and a homometric occurrence: the case of Alcm. frg. 3 Cal., vv. 87~101 | Alessio Faedda - Academia.edu](https://0.academia-photos.com/19326536/6256724/37045250/s200_alessio.faedda.jpg)
PDF) Birds, stars and a homometric occurrence: the case of Alcm. frg. 3 Cal., vv. 87~101 | Alessio Faedda - Academia.edu
![Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 - Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -](https://onlinelibrary.wiley.com/cms/asset/0dae3851-9a23-473d-bbb9-6a86aa4a983b/bjd.2015.172.issue-5.cover.jpg)
Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -
![Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 - Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -](https://onlinelibrary.wiley.com/cms/asset/1b64e26e-70d7-4306-bdac-52136782c88f/bjd13469-fig-0002-m.jpg)